Pentamidine inhibits prostate cancer progression via selectively inducing mitochondrial DNA depletion and dysfunction
Sign Up to like & getrecommendations! Published in 2019 at "Cell Proliferation"
DOI: 10.1111/cpr.12718
Abstract: We investigated the anti‐cancer activity of pentamidine, an anti‐protozoal cationic aromatic diamidine drug, in prostate cancer cells and aimed to provide valuable insights for improving the efficacy of prostate cancer treatment. read more here.
Keywords: inhibits prostate; progression via; pentamidine inhibits; prostate cancer ... See more keywords